Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.55T | 3.76T | 3.71T | 3.59T | 3.59T |
Gross Profit | 1.17T | 1.16T | 1.14T | 1.12T | 1.08T |
EBITDA | 445.80B | 370.73B | 457.57B | 446.38B | 471.68B |
Net Income | 219.81B | 254.48B | 215.18B | 182.69B | 202.70B |
Balance Sheet | |||||
Total Assets | 3.50T | 3.51T | 3.27T | 3.33T | 3.19T |
Cash, Cash Equivalents and Short-Term Investments | 236.08B | 342.14B | 355.90B | 484.02B | 481.83B |
Total Debt | 0.00 | 245.68B | 211.18B | 285.32B | 316.32B |
Total Liabilities | 1.60T | 1.60T | 1.53T | 1.62T | 1.64T |
Stockholders Equity | 1.74T | 1.75T | 1.59T | 1.59T | 1.45T |
Cash Flow | |||||
Free Cash Flow | 142.98B | 113.38B | 52.23B | 105.10B | 179.18B |
Operating Cash Flow | 303.88B | 309.22B | 220.33B | 248.35B | 307.95B |
Investing Cash Flow | -89.18B | -157.24B | -42.81B | -59.27B | -71.56B |
Financing Cash Flow | -240.45B | -181.49B | -313.58B | -193.69B | -219.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $43.55B | 16.74 | 11.82% | 0.44% | -8.93% | 45.37% | |
75 Outperform | $68.71B | 21.16 | 30.46% | 3.07% | 4.52% | -0.22% | |
74 Outperform | $33.88B | 14.09 | 16.69% | 1.74% | 6.34% | 12.16% | |
71 Outperform | $29.53B | 20.41 | 16.50% | 3.05% | -1.95% | 62.75% | |
70 Outperform | $153.32B | 19.59 | 27.27% | 2.40% | 6.21% | 14.87% | |
61 Neutral | $36.30B | 7.30 | -7.27% | 1.97% | 7.76% | -6.42% | |
58 Neutral | $37.39B | 267.99 | 1.01% | 2.15% | 3.64% | 102.21% |